SEARCH

SEARCH BY CITATION

References

  • Barrans, S., Crouch, S., Smith, A., Turner, K., Owen, R., Patmore, R., Roman, E. & Jack, A. (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 33603365.
  • Chuang, S.S., Ye, H., Du, M.Q., Lu, C.L., Dogan, A., Hsieh, P.P., Huang, W.T. & Jung, Y.C. (2007) Histopathology and immunohistochemistry in distinguishing burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. American Journal of Clinical Pathology, 128, 558564.
  • Dave, S.S., Fu, K., Wright, G.W., Lam, L.T., Kluin, P., Boerma, E.J., Greiner, T.C., Weisenburger, D.D., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Gascoyne, R.D., Delabie, J., Rimsza, L.M., Braziel, R.M., Grogan, T.M., Campo, E., Jaffe, E.S., Dave, B.J., Sanger, W., Bast, M., Vose, J.M., Armitage, J.O., Connors, J.M., Smeland, E.B., Kvaloy, S., Holte, H., Fisher, R.I., Miller, T.P., Montserrat, E., Wilson, W.H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W.C., Staudt, L.M. & Lymphoma/Leukemia Molecular Profiling Project (2006) Molecular diagnosis of burkitt’s lymphoma. The New England Journal of Medicine, 354, 24312442.
  • Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T.F., Bernd, H.W., Cogliatti, S.B., Dierlamm, J., Feller, A.C., Hansmann, M.L., Haralambieva, E., Harder, L., Hasenclever, D., Kuhn, M., Lenze, D., Lichter, P., Martin-Subero, J.I., Moller, P., Muller-Hermelink, H.K., Ott, G., Parwaresch, R.M., Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Sturzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H.H., Spang, R., Loeffler, M., Trumper, L., Stein, H., Siebert, R. & Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2006) A biologic definition of burkitt’s lymphoma from transcriptional and genomic profiling. The New England Journal of Medicine, 354, 24192430.
  • Johnson, N.A., Savage, K.J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M.J., Siebert, R., Kuruvilla, J., Klasa, R., Connors, J.M., Gascoyne, R.D. & Horsman, D.E. (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood, 114, 22732279.
  • de Jong, D., Xie, W., Rosenwald, A., Chhanabhai, M., Gaulard, P., Klapper, W., Lee, A., Sander, B., Thorns, C., Campo, E., Molina, T., Hagenbeek, A., Horning, S., Lister, A., Raemaekers, J., Salles, G., Gascoyne, R.D. & Weller, E. (2009) Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the lunenburg lymphoma biomarker consortium). Journal of Clinical Pathology, 62, 128138.
  • Keller, C.E., Nandula, S., Fisher, J., Subramaniyam, S., Vakiani, E., Savage, D.G., Murty, V.V., Alobeid, B. & Bhagat, G. (2008) The spectrum of B-cell non-hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. American Journal of Clinical Pathology, 130, 193201.
  • Kluin, P.M., Harris, N.L., Stein, H., Leoncini, L., Raphael, M., Campo, E. & Jaffe, E.S. (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 265. IARC, Lyon, France.
  • Ladanyi, M., Offit, K., Jhanwar, S.C., Filippa, D.A. & Chaganti, R.S. (1991) MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood, 77, 10571063.
  • Lenze, D., Leoncini, L., Hummel, M., Volinia, S., Liu, C.G., Amato, T., De Falco, G., Githanga, J., Horn, H., Nyagol, J., Ott, G., Palatini, J., Pfreundschuh, M., Rogena, E., Rosenwald, A., Siebert, R., Croce, C.M. & Stein, H. (2011) The different epidemiologic subtypes of burkitt lymphoma share a largely homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia, in press.
  • Leoncini, L., Raphael, M., Stein, H., Harris, N.L., Jaffe, E.S. & Kluin, P.M. (2008) Burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 262. IARC, Lyon, France.
  • Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., Tosi, P., van Krieken, H. & Leoncini, L. (2008) MYC translocation-negative classical burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. The Journal of Pathology, 216, 440450.
  • Mead, G.M., Barrans, S.L., Qian, W., Walewski, J., Radford, J.A., Wolf, M., Clawson, S.M., Stenning, S.P., Yule, C.L., Jack, A.S. & UK National Cancer Research Institute Lymphoma Clinical Studies Group & Australasian Leukaemia and Lymphoma Group (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood, 112, 22482260.
  • Niitsu, N., Okamoto, M., Miura, I. & Hirano, M. (2009) Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 23, 777783.
  • Piccaluga, P.P., De Falco, G., Kustagi, M., Gazzola, A., Agostinelli, C., Tripodo, C., Leucci, E., Onnis, A., Astolfi, A., Sapienza, M.R., Bellan, C., Lazzi, S., Tumwine, L., Mawanda, M., Ogwang, M., Calbi, V., Formica, S., Califano, A., Pileri, S.A. & Leoncini, L. (2011) Gene expression analysis uncovers similarity and differences among burkitt lymphoma subtypes. Blood, 117, 35963608.
  • Raphael, M., Gentilhomme, O., Tulliez, M., Byron, P.A. & Diebold, J. (1991) Histopathologic features of high-grade non-hodgkin’s lymphomas in acquired immunodeficiency syndrome. the french study group of pathology for human immunodeficiency virus-associated tumors. Archives of Pathology & Laboratory Medicine, 115, 1520.
  • van Rijk, A., Mason, D., Jones, M., Cabecadas, J., Crespo, M., Cigudosa, J.C., Garcia, J.F., Leoncini, L., Cocco, M., Hansmann, M.L., Mottok, A., Copie Bergman, C., Baia, M., Anagnostou, D., Pouliou, E., Hamilton Dutoit, S., Hjollund Christiansen, M., Svenstrup Poulsen, T., Hauge Matthiesen, S., van Dongen, J. & van Krieken, J.H. (2008) Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. Journal of Hematopathology, 1, 119126.
  • Rodig, S.J., Vergilio, J.A., Shahsafaei, A. & Dorfman, D.M. (2008) Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. The American Journal of Surgical Pathology, 32, 113122.
  • Snuderl, M., Kolman, O.K., Chen, Y.B., Hsu, J.J., Ackerman, A.M., Dal Cin, P., Ferry, J.A., Harris, N.L., Hasserjian, R.P., Zukerberg, L.R., Abramson, J.S., Hochberg, E.P., Lee, H., Lee, A.I., Toomey, C.E. & Sohani, A.R. (2010) B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from burkitt lymphoma and diffuse large B-cell lymphoma. The American Journal of Surgical Pathology, 34, 327340.
  • Tomita, N., Tokunaka, M., Nakamura, N., Takeuchi, K., Koike, J., Motomura, S., Miyamoto, K., Kikuchi, A., Hyo, R., Yakushijin, Y., Masaki, Y., Fujii, S., Hayashi, T., Ishigatsubo, Y. & Miura, I. (2009) Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica, 94, 935943.